311 related articles for article (PubMed ID: 4393719)
1. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
Frick MH; Katila M
Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
[No Abstract] [Full Text] [Related]
2. [Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol)].
Erikssen J; Rod T
Tidsskr Nor Laegeforen; 1971 Apr; 91(10):721-5. PubMed ID: 4397025
[No Abstract] [Full Text] [Related]
3. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.
Coltart DJ; Hamer J
Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080
[No Abstract] [Full Text] [Related]
4. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
Aellig WH; Prichard BN; Richardson GA
Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
[No Abstract] [Full Text] [Related]
5. [Adrenergic beta-blockade in angina pectoris. A study of the effects of Practolol (Eraldin, I.C.I. 50172) with special attention to the matter of dosage].
Christensen E; Busch M
Ugeskr Laeger; 1971 Feb; 133(7):296-9. PubMed ID: 4396025
[No Abstract] [Full Text] [Related]
6. Practolol in treatment of angina pectoris. A double-blind trial.
George CF; Nagle RE; Pentecost BL
Br Med J; 1970 May; 2(5706):402-4. PubMed ID: 4392984
[TBL] [Abstract][Full Text] [Related]
7. Practolol in patients with angina pectoris.
Alderman EL; Davis RO; Friedman JP; Graham AF; Matlof HJ; Harrison DC
Clin Pharmacol Ther; 1973; 14(2):175-81. PubMed ID: 4144425
[No Abstract] [Full Text] [Related]
8. Practolol in the treatment of ischaemic heart pain. Results of a controlled trial.
Nestel PJ
Med J Aust; 1972 May; 1(20):1033-5. PubMed ID: 4626799
[No Abstract] [Full Text] [Related]
9. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
10. Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris.
Nellen M
S Afr Med J; 1969 Dec; ():Suppl:15-7. PubMed ID: 4392020
[No Abstract] [Full Text] [Related]
11. -Receptor antagonists in angina pectoris.
Prichard BN
Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
[No Abstract] [Full Text] [Related]
12. Practolol in angina.
Phear DN
Br Med J; 1971 Mar; 1(5748):557. PubMed ID: 4396083
[No Abstract] [Full Text] [Related]
13. Effect of practolol on exercise tolerance in patients with angina pectoris.
Sowton E; Smithen C; Leaver D; Barr I
Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
Sandler G; Clayton GA
Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
[TBL] [Abstract][Full Text] [Related]
15. The effects of practolol on angina pectoris induced by atrial pacing.
Gavrilescu S; Streian C; Pop T
Cor Vasa; 1972; 14(4):259-64. PubMed ID: 4146675
[No Abstract] [Full Text] [Related]
16. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
[TBL] [Abstract][Full Text] [Related]
17. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
Prahl P; Prahl M
Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
[No Abstract] [Full Text] [Related]
18. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris].
Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B
Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507
[No Abstract] [Full Text] [Related]
19. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol].
Liljedal J
Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226
[No Abstract] [Full Text] [Related]
20. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
